Table 1 Characterization of the cancer patient cohort
Male | Age mean ± SD | Female | Age mean ± SD | MMR and/or MSI tests | MMR and MSI tests | |
|---|---|---|---|---|---|---|
Cancers | 701 | 65 ± 8.9 | 605 | 64 ± 9.2 | 1306 | 703 |
Colorectal | 556 | 65 ± 8.8 | 422 | 65 ± 9.0 | 978 | 543 |
Endometrial | 39 | 59 ± 9.3 | 39 | 27 | ||
Pancreatic | 15 | 67 ± 7.4 | 21 | 61 ± 8.0 | 36 | 14 |
Gastric | 22 | 67 ± 9.3 | 11 | 71 ± 9.2 | 33 | 27 |
Biliary | 8 | 65 + 6.8 | 12 | 67 ± 6.8 | 20 | 10 |
Esophageal | 13 | 65 + 6.5 | 3 | 54 ± 6.9 | 16 | 13 |
Ovarian | 14 | 58 ± 10.2 | 14 | 10 | ||
Breast | 11 | 51 ± 7.5 | 11 | 4 | ||
Liver | 4 | 48 ± 7.1 | 6 | 71 ± 11.9 | 10 | 3 |
Others | 17 | 60 ± 11.0 | 6 | 63 ± 12.1 | 23 | 12 |
CUP | 66 | 63 ± 9.4 | 60 | 61 ± 9.4 | 126 | 40 |